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Abstract 
Review on GPX1, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: GPXD, GSHPX1 
HGNC (Hugo): GPX1 
Location: 3p21.31 
Local order 
- C3orf62, chr3:49306030-49314508, chromosome 
3 open reading frame 62 
- USP4, 3p21.31, chr3:49314577-49377536, 
ubiquitin specific peptidase 4 (proto-oncogene), 
transcript variant 2 
- USP4, 3p21.31, chr3:49314577-49377536, 
ubiquitin specific peptidase 4 (proto-oncogene), 
transcript variant 1 
- USP4, 3p21.31, chr3:49349218-49377536, 
ubiquitin specific peptidase 4 (proto-oncogene), 
transcript variant 3 
- GPX1, 3p21.31, chr3:49394609-49395791, 
glutathione peroxidase 1, transcript variant 1 
- GPX1, 3p21.31, chr3:49394609-49395791, 
glutathione peroxidase 1, transcript variant 2 
- RHOA, 3p21.31, chr3:49396579-49449526, ras 
homolog family member A 
- TCTA, 3p21.31, chr3:49449639-49453909, T-cell 
leukemia translocation altered 
- AMT, 3p21.31, chr3:49454211-49460111, 
aminomethyltransferase 
The colocalization of genes is presented on figure 1. 
Note 
According to hg19/GRCh37-Feb_2009: 
- GPX1 at chr3:49394609-49395791 - 
(NM_000581) glutathione peroxidase 1 isoform 1 
- GPX1 at chr3:49394609-49395791 - 
(NM_201397) glutathione peroxidase 1 isoform 2 
GPX1 is an enzyme that reduces hydrogen and lipid 
peroxides to water or alcohols by reducing 
glutathione. Systematic name: glutathione: 
hydrogen-peroxide oxidoreductase. 
Reaction: 2 glutathione + H2O2 = glutathione 
disulfide + 2 H2O [RN:R00274]. 
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DNA/RNA 
Description 
According to hg19/GRCh37-Feb_2009: 
- Start: chr3:49394609 bp from pter 
- End: chr3:49395791 bp from pter 
- Size: 1183 bases 
- Orientation: minus strand 
Transcription 
Two alternatively spliced transcript variants 
encoding distinct isoforms have been shown for this 
gene (Nucleotide). 
Isoform 1 represents the shorter transcript (921 
bases), RefSeq: NM_000581.2, which is comprised 
of 2 exons and coding the longer isoform (Figure 
2A). 
Isoform 2 is 1200 bases, RefSeq: NM_201397.1, 
also this variant is intronless.  
Due to the fact that this variant is not spliced the 
open reading frame is shifted and the protein is 
shorter from C-terminus compared to isoform 1 
(Figure 2B). 
Pseudogene 
Two pseudogenes have been found so far. GPX1P1 
glutathione peroxidase pseudogene 1 (other names: 
GPXL2, GPXP1) is located at the locus Xp22.2 
(HGNC:4560). GPX1P2 glutathione peroxidase 
pseudogene 2 (other names: GPXP2, GPXP2P) is 
located at the locus 21q21.3 (HGNC:4561). 
Protein 
Description 
203 aa (Accession: NM_000581.2) isoform 1; 98 aa 
(Accession: NM_201397.1) isoform 2. 
GPX1 belongs to the family of glutathione 
peroxidases (Kryukov et al., 2003).  
GPX1, GPX2, GPX3, GPX4 and GPX6 utilize a 
UGA codon that specifies insertion of a 
selenocysteine residue which is critical to protein 
function (Arthur, 2000). Both isoforms contain 
selenocysteine at the position 49 (Mullenbach et al., 
1988). 
Expression 
GPX1 is found at high levels in tissues exposed to 
high oxygen tensions such as in the lungs, at the 
cellular elements of blood, liver, kidney and 
pancreas, and also at moderate levels in heart, 
muscle and brain (Esposito et al., 2000; Moscow et 
al., 1992).  
Regulation: Aberrant promotor methylation and 
consequence silencing has been shown for GPX1 
expression during several pathological conditions in 
breast (Kulak et al., 2012) and gastric cancer (Min 
et al., 2012); whereas, induction of GPX1 gene 
expression was associated with transcription factors 
such TFAP2C in breast cancer (Kulak et al., 2012) 
and ZNF143 transcription factor under the 
mitochondrial respiratory dysfunction (Lu et al., 
2012). 
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Localisation 
The protein is detected in cytoplasm and 
mitochondria but the ratio may vary and be 
dependent on cellular function (Chiu et al., 1976; 
Timcenko-Youssef et al., 1985; Reeves et al., 
2009). 
Function 
GPX1 is an enzyme of mammals and birds which 
protects against the damaging effects of various 
endogenously formed hydroperoxides and hydrogen 
peroxide as follows: H2O2+ 2 GSH - 2 H2O + GSS 
and RGOH + 2 GSH - GSSG + ROH + H2O where 
ROOH represents lipid hydroperoxides, membrane 
associated phospholipid hydroperoxides (Ursini et 
al., 1985; Reeves et al., 2009). 
Homology 
The GPX1 gene is present in vertebrates and across 
all mammals demonstrates homology of about 70% 
at the nucleotide level (Mariotti et al., 2012). 
Mutations 
Note 
Single nucleotide and ALA polymorphism have 
been shown for GPX1.  
The 5'-UTR of GPX1 was found to contain a single 
nucleotide C/T polymorphism rs 1800668 located at 
the position ch3:49395757. The CC genotype 
demonstrates relatively high activity of GPX1 
compared to CT or TT variant of alleles; however, 
the polymorphism does not alter the protein 
structure so differences in activity might be 
associated with transcriptional regulation since rs 
1080668 site is located within promoter of GPX1 
(Najafi et al., 2012). 
A single nucleotide polymorphism rs 1050450 at 
the position ch3:49394834 leads to Pro198->Leu 
(C->T) substitution in GPX1. Many publications 
suggested an associated increased risk of cancer 
with the TT (Leu) genotype.  
However, extended meta-analysis failed to find a 
significant correlation of the polymorphism (rs 
1050450) with cancer risk, although the TT GPX1 
genotype examined in erythrocytes demonstrated 
significantly lower functional activity (Hong et al., 
2012). 
ALA N-terminal polymorphism has been shown for 
the GPX1 gene. In this variant, the number of GCG 
repeats is altered resulting in a protein with a 
variable number of alanines 5, 6, or 7 (Shen et al., 
1994).  
Some association between 5-ALA genotype and 
high risk of breast cancer have been shown (Knight 
et al., 2004). However, associations between 
specific genotypes and the risk of prostate cancer 
have not been found (Kote-Jarai et al., 2002). 
Implicated in 
Various cancers 
Oncogenesis 
GPX1 involvment in certain cancers has been 
shown by several line of evidence. 
Lung cancer 
Note 
The expression of GPX1 may be altered through 
LOH (loss of heterozygosity) of GPX1 which leads 
to decrease gene activity and increased risk of lung 
cancer (Hardie et al., 2000). Up-regulation of GPX1 
in erythrocytes may be seen under several 
conditions such as hypoxia or with treatment with 
chemicals such as alcohol (Raaschou-Nielsen et al., 
2006) but GPX1 activity tended to be significantly 
lower in smokers compared to non-smokers (Ravn-
Haren et al., 2006) and these differences have been 
hypothesized to account for increased risk of lung 
cancer in smokers (Ratnasinghe et al., 2000). 
However high level of GPX1 was shown in lung 
cancer compared to non-malignant tissue 
(Blomquist et al., 2009). 
Breast cancer 
Note 
Decrease GPX1 activity due to LOH (Hu et al., 
2003; Hu et al., 2005) or aberrant hypermethylation 
of the GPX1 gene promotor (Kulak et al., 2012) 
leads to high risk of breast cancer. 
Renal cancer 
Note 
Selenium consumption plays a dramatic role on 
GPX1 activity. Selenium in the diet altered both the 
mRNA and protein levels of GPX1 in mice (Sunde 
et al., 2009) whereas in pigs selenoprotein gene 
expression and/or protein production is not 
dependent on prolonged dietary selenium 
deficiency or excess (Liu et al., 2012). In humans 
no association was found between the Se status and 
breast or colorectal cancer risk (Dennert et al., 
2011), but poor Se status was indicative of high 
mortality rate in renal cancer patients (Jean-Claude 
et al., 2012; Meyer et al., 2012). 
Gastric cancer 
Note 
Aberrant hypermethylation of the GPX1 gene 
promotor may decrease GPX1 expression and has 
been described as a mechanism of GPX1 silencing 
in gastric cancer (Jee et al., 2009). 
Bladder cancer 
Note 
Relatively high level of GPX1 was observed in 
bladder cancer (Reszka, 2012). 
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Anticancer drug resistance 
Note 
One hypothesis proposes that when damaged cells 
have progressed to a precancerous status, increased 
GPX1 activity may become procarcinogenic, 
presumably due to inhibition of hydroperoxide-
mediated apoptosis (Chu et al., 2004) and may be 
responsible for antitumor drug resistance such as 
doxorubicin (Gouazé et al., 2001) which acts 
through increasing ROS products in cells (Wang et 
al., 2004). 
Genetic polymorphisms and cancer 
Note 
As mentioned above, genetic polymorphisms have 
been reported for GPX1.  
Investigations have attempted to demonstrate an 
association with cancer incidence, however, no 
consistent association has been found to date (Lei et 
al., 2007; Arsova-Sarafinovska et al., 2009; Erdem 
er al., 2012; Hong et al., 2012). 
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